Evidence map›Paper›PMID 25660637›Full record

ReviewNeuropharmacology2015

Inside-out neuropharmacology of nicotinic drugs.

Brandon J Henderson, Henry A Lester

Abstract readReview
In one paragraph

Review in Neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Synthetic cooling agents enhance nicotine reinforcement and mesolimbic dopamine signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Continuous Nicotine Monitors for Personal Nicotine Pharmacokinetics: A Receptor-Aware Research Agenda.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Antidepressants enter cells, organelles, and membranes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  16. Article
  17. Xanomeline restores endogenous nicotinic acetylcholine receptor signaling in mouse prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  18. Article
  19. Article
  20. Morphine Exposure Reduces Nicotine-Induced Upregulation of Nicotinic Receptors and Decreases Volitional Nicotine Intake in a Mouse Model.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Brandon J HendersonDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Henry A LesterDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Electronic address: Lester@Caltech.edu.

Funding

Project 3 University of Colorado, BoulderU19DA019375 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2005 to 2014
$8.3M
Alpha4 Nicotinic Receptor in Addiction: Mouse ModelsR01DA017279 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2004 to 2014
$3.5M
PROBING RECEPTOR STRUCTURES WITH UNNATURAL AMINO ACIDSR01NS034407 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DOUGHERTY, DENNIS A · 1995 to 2016
$3.1M
Probing Receptor Structures with Unnatural Amino AcidsR37NS034407 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DOUGHERTY, DENNIS A · 2004 to 2010
$2.7M
Chronic nicotine: cell-specific receptor and circuit alterations in basal gangliaR01AG033954 · NIA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2009 to 2013
$1.7M
Mice with Functional Fluorescent Nicotinic Receptor SubunitsRC2DA028955 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2009 to 2010
$1.6M
Tools for inside-out pharmacology: nicotinic agentsR01DA037161 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2013 to 2016
$1.3M
Alpha6* nAChRs in Dopamine Transmission and Nicotine DependenceR00DA030396 · NIDA · PURDUE UNIVERSITY · PI DRENAN, RYAN MICHAEL · 2011 to 2013
$709k
Expression and Characterization of alpha6beta2beta3 nicotinic receptorsF32DA033721 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI HENDERSON, BRANDON JARROD · 2012 to 2014
$150k
Alpha6* nAChRs in Dopamine Transmission and Nicotine DependenceK99DA030396 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI DRENAN, RYAN MICHAEL · 2010 to 2010
$90k
NIA NIH HHS AG033954NIA NIH HHS R01 AG033954NIDA NIH HHS DA017279NIDA NIH HHS DA019375NIDA NIH HHS DA030396NIDA NIH HHS DA033721NIDA NIH HHS F32 DA033721NIDA NIH HHS K99 DA030396NIDA NIH HHS R00 DA030396NIDA NIH HHS R01 DA017279NIDA NIH HHS R01 DA037161NIDA NIH HHS RC2 DA028955NIDA NIH HHS U19 DA019375NINDS NIH HHS NS034407NINDS NIH HHS R01 NS034407NINDS NIH HHS R37 NS034407
6 · The paper itself

Abstract

Upregulation of neuronal nicotinic acetylcholine receptors (AChRs) is a venerable result of chronic exposure to nicotine; but it is one of several consequences of pharmacological chaperoning by nicotine and by some other nicotinic ligands, especially agonists. Nicotinic ligands permeate through cell membranes, bind to immature AChR oligomers, elicit incompletely understood conformational reorganizations, increase the interaction between adjacent AChR subunits, and enhance the maturation process toward stable AChR pentamers. These changes and stabilizations in turn lead to increases in both anterograde and retrograde traffic within the early secretory pathway. In addition to the eventual upregulation of AChRs at the plasma membrane, other effects of pharmacological chaperoning include modifications to endoplasmic reticulum stress and to the unfolded protein response. Because these processes depend on pharmacological chaperoning within intracellular organelles, we group them as "inside-out pharmacology". This term contrasts with the better-known, acute, "outside-in" effects of activating and desensitizing plasma membrane AChRs. We review current knowledge concerning the mechanisms and consequences of inside-out pharmacology. This article is part of the Special Issue entitled 'The Nicotinic Acetylcholine Receptor: From Molecular Biology to Cognition'.

Indexed as

AnimalsBrainEndoplasmic Reticulum StressHumansNeuronsNeuropharmacologyNicotineNicotinic AgonistsProtein ConformationReceptors, NicotinicTobacco Use DisorderUnfolded Protein ResponseUp-RegulationNicotineNicotinic AgonistsReceptors, NicotinicChaperoningNicotineNicotine addictionNicotinic receptorsUnfolded protein responseUpregulation

Identifiers

PMID25660637
PMCPMC4486611

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.